Xenetic Biosciences, Inc. Enters into Research Agreement with the University of Virginia for the Advancement of its DNase-Based Oncology Platform

- Company building growing body of preclinical data to guide pathway to first in human trial for DNase-based oncology platform

Related Keywords

Russia ,Ukraine ,Russian ,Jeffrey Eisenberg ,Jenene Thomas ,Xenetic Biosciences ,Allan Tsung ,Research Funding Agreement ,Xenetic Biosciences Inc ,Company Dnase ,Nasdaq ,Facebook ,Twitter ,University Of Virginia ,Company Scientific Advisory Board ,School Of Medicine ,Linkedin ,Department Of Surgery ,Material Transfer Agreement ,Scientific Advisory Board ,Chief Executive Officer ,Private Securities Litigation Reform Act ,Region ,